Ixazomib, lenalidomide and dexamethasone consolidation with randomized ixazomib or lenalidomide maintenance after autologous transplant in newly diagnosed multiple myeloma.
Michael Joseph SladeThomas G MartinNitya NathwaniMark A FialaMichael P RettigFeng GaoAbhinav DeolFrancis K BuadiJonathan L KaufmanCraig C HofmeisterTara K GregoryJesus G BerdejaAjai ChariAshley RoskoRavi VijPublished in: Leukemia (2022)